glucotrol xl 5 mg ilgstošās darbības tabletes
pfizer europe ma eeig, belgium - glipizīds - modificētās darbības tablete - 5 mg
glucotrol xl 10 mg ilgstošās darbības tabletes
pfizer europe ma eeig, belgium - glipizīds - modificētās darbības tablete - 10 mg
nimotop s 30 mg apvalkotās tabletes
bayer ag, germany - nimodipīns - apvalkotā tablete - 30 mg
nimotop s 30 mg apvalkotās tabletes
bayer ag, germany - nimodipīns - apvalkotā tablete - 30 mg
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloģiskie līdzekļi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.